$GALE Recent Headlines FutureFuel shares rally
Post# of 74551
Posted On: 10/30/2014 9:40:01 AM
$GALE Recent Headlines
FutureFuel shares rally on big profit jump 5:20 p.m. March 17, 2014 - Wallace Witkowski
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck
Galena gets NOA for NeuVax patent app in Japan 12:59 p.m. Oct. 14, 2014 - Seeking Alpha
FDA clears Akynzeo for chemo-induced nausea and vomiting 10:50 a.m. Oct. 10, 2014 - Seeking Alpha
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape 9:00 a.m. Oct. 9, 2014 - Zacks.com
Three Lessons From The Galena Scandal 11:02 a.m. Aug. 21, 2014 - Seeking Alpha
Galena Biopharma (GALE) Replaces CEO Mark Ahn 10:10 a.m. Aug. 21, 2014 - InvestorPlace.com
Galena CEO gets the boot 7:33 a.m. Aug. 21, 2014 - Seeking Alpha
Galena CEO Fired Following Stock-Promotions Scandal 7:16 a.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 7:22 a.m. Aug. 15, 2014 - TheStreet.com
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings Call Transcript 9:17 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 5:19 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
20 Cheap Stocks Under $10 Worth Zilch 5:40 a.m. Aug. 5, 2014 - InvestorPlace.com
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Galectin Pays Stock Promoters to Entice Retail Investors 12:34 p.m. July 28, 2014 - TheStreet.com
Galena Gives Sales Team Another Useless Product to Promote 9:41 a.m. July 22, 2014 - TheStreet.com
Galena secures U.S. rights to serotonin blocker 8:33 a.m. July 22, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 11:11 a.m. July 8, 2014 - Barrons.com
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 9:49 a.m. July 2, 2014 - TheStreet.com
Galena receives notice of allowance of NeuVax patent 8:14 a.m. July 1, 2014 - Seeking Alpha
Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal 9:52 a.m. June 18, 2014 - TheStreet.com
GALE-301 Phase 2a clinical trial enrollment complete 7:53 a.m. June 17, 2014 - Seeking Alpha
Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 7:06 a.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 8:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan 7:05 a.m. Oct. 14, 2014 - GlobeNewswire
Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination 7:06 a.m. Oct. 8, 2014 - GlobeNewswire
Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update 4:15 p.m. Sept. 25, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial 7:05 a.m. Sept. 9, 2014 - GlobeNewswire
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 7:06 a.m. Sept. 3, 2014 - GlobeNewswire
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer 7:05 a.m. Aug. 21, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 7:06 a.m. July 29, 2014 - GlobeNewswire
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film 7:16 a.m. July 22, 2014 - GlobeNewswire
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film 7:06 a.m. July 22, 2014 - GlobeNewswire
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S) 7:06 a.m. July 1, 2014 - GlobeNewswire
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell 5:10 a.m. June 26, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference 7:05 a.m. June 19, 2014 - GlobeNewswire
Galena Biopharma Recent Events will Continue to Weigh In on Shares, Analyst Report by BrokerBank Securities, Inc. 1:30 p.m. June 17, 2014 - PR Newswire - PRF
Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers 7:06 a.m. June 17, 2014 - GlobeNewswire
FutureFuel shares rally on big profit jump 5:20 p.m. March 17, 2014 - Wallace Witkowski
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck
Galena gets NOA for NeuVax patent app in Japan 12:59 p.m. Oct. 14, 2014 - Seeking Alpha
FDA clears Akynzeo for chemo-induced nausea and vomiting 10:50 a.m. Oct. 10, 2014 - Seeking Alpha
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape 9:00 a.m. Oct. 9, 2014 - Zacks.com
Three Lessons From The Galena Scandal 11:02 a.m. Aug. 21, 2014 - Seeking Alpha
Galena Biopharma (GALE) Replaces CEO Mark Ahn 10:10 a.m. Aug. 21, 2014 - InvestorPlace.com
Galena CEO gets the boot 7:33 a.m. Aug. 21, 2014 - Seeking Alpha
Galena CEO Fired Following Stock-Promotions Scandal 7:16 a.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 7:22 a.m. Aug. 15, 2014 - TheStreet.com
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings Call Transcript 9:17 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 5:19 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
20 Cheap Stocks Under $10 Worth Zilch 5:40 a.m. Aug. 5, 2014 - InvestorPlace.com
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Galectin Pays Stock Promoters to Entice Retail Investors 12:34 p.m. July 28, 2014 - TheStreet.com
Galena Gives Sales Team Another Useless Product to Promote 9:41 a.m. July 22, 2014 - TheStreet.com
Galena secures U.S. rights to serotonin blocker 8:33 a.m. July 22, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 11:11 a.m. July 8, 2014 - Barrons.com
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 9:49 a.m. July 2, 2014 - TheStreet.com
Galena receives notice of allowance of NeuVax patent 8:14 a.m. July 1, 2014 - Seeking Alpha
Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal 9:52 a.m. June 18, 2014 - TheStreet.com
GALE-301 Phase 2a clinical trial enrollment complete 7:53 a.m. June 17, 2014 - Seeking Alpha
Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 7:06 a.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 8:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan 7:05 a.m. Oct. 14, 2014 - GlobeNewswire
Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination 7:06 a.m. Oct. 8, 2014 - GlobeNewswire
Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update 4:15 p.m. Sept. 25, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial 7:05 a.m. Sept. 9, 2014 - GlobeNewswire
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 7:06 a.m. Sept. 3, 2014 - GlobeNewswire
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer 7:05 a.m. Aug. 21, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 7:06 a.m. July 29, 2014 - GlobeNewswire
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film 7:16 a.m. July 22, 2014 - GlobeNewswire
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film 7:06 a.m. July 22, 2014 - GlobeNewswire
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S) 7:06 a.m. July 1, 2014 - GlobeNewswire
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell 5:10 a.m. June 26, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference 7:05 a.m. June 19, 2014 - GlobeNewswire
Galena Biopharma Recent Events will Continue to Weigh In on Shares, Analyst Report by BrokerBank Securities, Inc. 1:30 p.m. June 17, 2014 - PR Newswire - PRF
Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers 7:06 a.m. June 17, 2014 - GlobeNewswire
(0)
(0)